Michael Steiner - Dr Ing Member RD

DRPRY Stock   6.45  0.14  2.22%   

Insider

Michael Steiner is Member RD of Dr Ing hc
Age 59
Phone49 711 911 0
Webhttps://www.porsche.com/international

Michael Steiner Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael Steiner against Dr Ing pink sheet is an integral part of due diligence when investing in Dr Ing. Michael Steiner insider activity provides valuable insight into whether Dr Ing is net buyers or sellers over its current business cycle. Note, Dr Ing insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dr Ing'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Similar Executives

Showing other executives

INSIDER Age

Scott HamiltoniHeartMedia
53
Bradford TobinMediaco Holding
41
Wendy GoldbergiHeartMedia
59
Rdiger BssProSiebenSat1 Media AG
N/A
Robert PittmaniHeartMedia
69
Wolfgang LinkProSiebenSat1 Media AG
Scott EsqMediaco Holding
61
Ann BeemishMediaco Holding
51
Stefanie RuppMenedetterProSiebenSat1 Media AG
N/A
Susanne BrieuProSiebenSat1 Media AG
N/A
Jeff HowardiHeartMedia
N/A
Michael McGuinnessiHeartMedia
46
Kyla MullinsITV PLC ADR
N/A
Tracy CleetonSaga Communications
N/A
Bjrn BauerRTL Group SA
43
Bert HabetsProSiebenSat1 Media AG
52
Steve MillsiHeartMedia
64
Gayle TrobermaniHeartMedia
N/A
Sallie KimbroughCumulus Media Class
N/A
Christina AlbeeCumulus Media Class
N/A
General HeggenRTL Group SA
55
Dr Ing hc [DRPRY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Dr Ing hc Leadership Team

Elected by the shareholders, the Dr Ing's board of directors comprises two types of representatives: Dr Ing inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DRPRY. The board's role is to monitor Dr Ing's management team and ensure that shareholders' interests are well served. Dr Ing's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Ing's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lutz Meschke, CFO Board
Michael Steiner, Member RD
Albrecht Reimold, Member Logistics
Detlev Platen, Head Board
Barbara Frenkel, Member Procurement
Andreas Haffner, Member Affairs
Oliver Blume, Chairman CEO

DRPRY Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Dr Ing a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for DRPRY Pink Sheet Analysis

When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.